Amendment to pre-order trial for Fluoroquinolone Products
Amendment to pre-order trial for Fluoroquinolone Products
Introduction
The pretrial schedule for the first bellwether trials involving Cipro and Avelox was amended to extend the non-expert fact discovery deadline until January 26, 2018. Fluoroquinolone or peripheral neuropathy lawsuits involving Avelox, Cipro, and Levaquin are a part of the multidistrict litigation 2642 in the U.S. District Court, District of Minnesota. January 19, 2018, is the deadline for completion of case-specific discovery for Avelox-only and Cipro-only cases. As of today, the bellwether trials begin from November 2018 for the Avelox-only cases and from March 4, 2019, for the Cipro-only cases
Comments
Latest News
Walgreens Settles Federal Opioid Case for $300 Million
Categories: Opioids
Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.
The U.S. Department of Justice announced on Monday…
Study: Opioid Use in Pregnancy May Shrink Newborn Brains
Categories: Opioids
New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…
Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting
Categories: Opioids
The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…